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Abstract
Estrogen exerts diverse biological effects in multiple tissues in both animals and humans. Much of the accumulated
knowledge on the role of estrogen receptor (ER) in the heart has been obtained from studies using ovariectomized mice,
whole body ER gene knock-out animal models, ex vivo heart studies, or from isolated cardiac myocytes. In light of the wide
systemic influence of ER signaling in regulating a host of biological functions in multiple tissues, it is difficult to infer the
direct role of ER on the heart. Therefore, we developed a mouse model with a cardiomyocyte-specific deletion of the ERa
allele (cs-ERa2/2). Male and female cs-ERa2/2 mice with age/sex-matched wild type controls were examined for differences
in cardiac structure and function by echocardiogram and differential gene expression microarray analysis. Our study
revealed sex-differences in structural parameters in the hearts of cs-ERa2/2 mice, with minimal functional differences.
Analysis of microarray data revealed differential variations in the expression of 208 genes affecting multiple transcriptional
networks. Furthermore, we report sex-specific differences in the expression of 56 genes. Overall, we developed a mouse
model with cardiac-specific deletion of ERa to characterize the role of ERa in the heart independent of systemic effects. Our
results suggest that ERa is involved in controlling the expression of diverse genes and networks in the cardiomyocyte in a
sex-dependent manner.
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Introduction
Estrogen receptors (ER) are involved in multiple biological
processes in a variety of tissues including the cardiovascular
system, adipose tissue, and sex organs [1]. Generally, the actions of
ERs are triggered upon binding of estrogens such as 17-b estradiol
(E2), the predominant active form of estrogen [2]. Upon ligand
binding, ERs mediate their response by two possible modes of
action: genomic, which elicits a slow response, and non-genomic,
which induces a rapid response. Genomic activation of ERs
initiate transcription factors either by direct DNA interaction
through estrogen response elements (ERE) or through ER-DNA
indirect interactions by tethering with known transcription factors
bound to the DNA [3]. The non-genomic actions, on the other
hand, are mostly membrane-initiated and involve signaling
cascades, such as the mitogen-activated protein kinase (MAPK)
pathway, the cyclic adenosine mono-phosphate/protein kinase A
(cAMP/PKA) pathway, or the endothelial nitric oxide synthase
(eNOS) pathway [4–6].
ERs have been implicated in several pathophysiological
conditions including diabetes and obesity with implications for
cardiovascular disease [1,7]. In the heart, cardiomyocytes express
both sub-types of ER, ERa and ERb, with significantly higher
levels of ERa [8–10]. Mice with whole-body deletion of ERa have
been shown to exhibit altered cardiac substrate preference,
particularly uptake and maintenance of glucose in the heart
[11]. Indeed, whole-body ERa knockout mice are obese and
insulin resistant [12–14] and exhibit diminished rates of fatty acid
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(FA) oxidation in skeletal muscle [13]. ERa is also thought to
possess cardio-protective properties, due to its ability to up-
regulate expression of ApoE, an apolipoprotein that increases
clearance of low density lipoproteins (LDL) from circulation
[15,16]. Similarly, ERb has been reported to mediate sex-
differences in ischemia/reperfusion injury [17,18] as well as
protect against left-ventricular hypertrophy (LVH) in females [19].
Interestingly, ERa and ERb have also been reported to
differentially modulate the expression of inflammatory markers,
in particular that of inducible nitric oxide synthase (iNOS) [20].
Nevertheless, to date, the studies describing the role of ERs on the
cardiovascular system were based on whole-body ER knockouts or
on the effects of ER ligands, such as estrogen, on the heart, but
with the caveat that such ER ligands also affect peripheral tissues.
In light of the wide influence of ER signaling in regulating
physiologic functions in multiple tissues, including systemic energy
homeostasis, and considering that peripheral substrates can induce
cardio-metabolic remodeling, it is difficult to infer the direct role of
ER on the heart using whole-body KO models.
As a first step in characterizing the role of ERs in the heart,
independent of systemic effects of ERs, we have generated a mouse
model with a cardiomyocyte-specific deletion of ERa (cs- ERa2/
2. The availability of mice with cs-ERa2/2 will enable, for the
first time, to investigate the role of ERa in cardiac tissue
independent of peripheral effects. In addition, since ERs are
important therapeutic targets, development of in vivo models of
selective modulation (such as cardiac specific deletion) will enable
better understanding of ER effects in specific tissue [21,22]. To
that end, we characterized basal cardiac structure and function,
and performed gene expression microarray profiling to determine
differentially affected networks and pathways in male and female
mice. Statistically validated results from the microarray analyses
were used for pathway analysis, with emphasis on transcriptional
factors and receptor networks (for deciphering genomic actions of
ERa). Our findings indicate that cs- ERa2/2 manifests significant
variations in the expression profile of genes involved in metabo-
lism, cell growth and differentiation, muscle architecture, and
relaxation. Finally, we delineate sex differences associated with the
absence of ERa in the heart and identify key transcriptional/
receptor hubs that are involved in ERa mediated regulation/
signaling in cardiac tissue.
Materials and Methods
All experiments were conducted according to a protocol
approved by the animal experiment committee at Washington
University School of Medicine in Saint Louis (IACUC Animal
Welfare Assurance # A-3381-01) and in accordance to ‘Principles
of laboratory animal care’ (NIH pub no. 85–23, revised 1985;
http://grants1.nih.gov/grants/olaw/references/phspol.htm). Ani-
mals were housed in AAALAC-Accredited animal facility overseen
by experienced veterinary personnel and animal care staff.
Animals were euthanized via carbon dioxide inhalation, and all
efforts were made to minimize suffering.
Generation of cardiomyocyte specific ERa knockout mice
Mice with cardiomyocyte-specific ERa deficiency were gener-
ated by crossing mice with Exon 3-floxed ERa alleles obtained
from NIEHS [23] with mice expressing Cre recombinase in a
cardiomyocyte specific manner (a-MHC-Cre). Mouse tail digest
was used for genotyping. PCR screening was performed for Cre
recombinase using the forward primer CGGTCAACGTG-
CAAAACAGGCTCTA and reverse primer CTTCCAG-
GGCGCGAGTTGA TAGC. The expression of ERa in cardiac
tissue of the knockout mice were quantitatively measured by qRT-
PCR using ERa Specific Primetime Assay primers (IDT DNA,
Coralville, Iowa). The sequences of the forward and reverse
primer used are ATGGTCATGGTAAGTGGCA and CCTCT-
GCCATTGTCTAGCTT, respectively. Both male and female
Knockout animals showed reduced expression of the ERa gene in
the cardiac tissue as shown in Figure 1.
Animal Studies
Wild type (ERaflox/flox) and cardiomyocyte-specific ERa
knockout (cs-ERa2/2) male and female mice of C57BL/6
phenotype were bred and maintained at Washington University
School of Medicine animal facility. Mice had free access to regular
diet and water. At approximately 18–20 weeks of age, four mice
from each group (total of 16 mice) were sacrificed after drawing
blood for biochemical analysis, and their hearts were isolated and
flash frozen for further analysis. Serum was separated by
centrifugation from the collected blood samples for measurement
of non-esterified fatty acids (NEFA), triglycerides (TG) and
cholesterol concentrations. All experiments were performed in
compliance with the guidelines for the care and use of research
animals established by Animal Studies Committee of Washington
University in St. Louis School of Medicine.
Biochemical analysis
Serum NEFA, TG, and cholesterol concentrations were
determined by using commercial kits for NEFA (Wako Diagnos-
tics, VA), TG (Infinity Triglycerides Reagent, Thermo Scientific,
USA), and cholesterol (Infinity total cholesterol, Thermo Scien-
tific, USA). These assays were performed by the Diabetes
Research Center (DRC) at Washington University School of
Medicine. Blood glucose concentrations were measured by using
commercial blood test strips (Accu-Check, Roche, USA) by using a
drop of tail blood.
Echocardiogram
Echocardiograms were performed using non-invasive ultra-
sound imaging with the Vevo2100 Ultrasound System (Visual
Sonics Inc., Toronto, Ontario, Canada) at 18–20 weeks of age as
Figure 1. Extent of ERa knockout in the cardiac tissue: RNA
from N=3/group mice were isolated and expression analyzed
using primetime assay primers from IDT DNA (Iowa). {
represents genotype significance, Two-Way ANOVA and * indicates
significant difference within sex (Contrast Analysis by Tumhane and
Dunlop Method [37]). P,0.05 was considered significant for both.
doi:10.1371/journal.pone.0101900.g001
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described previously [19]. Briefly, mice were anesthetized with
Avertin (2% solution, 0.05 mg/g body weight, IP) and secured to
the imaging platform. Complete 2-dimensional, M-mode, and
Doppler examinations using a 30 MHz transducer were
performed to quantify left ventricular structure as well as diastolic
and systolic function. All dimensional measurements were indexed
to body weight.
Microarray analysis
Total RNA was extracted from ,50 mg of pulverized cardiac
tissues using Qiagen Universal RNA isolation kit (Qiagen,
Frederick, MD) following the manufacturer’s recommended
protocol. On-column DNase removal was performed and total
RNA concentration and purity were measured by absorbance
ratio at 260 nm and 280 nm. Total RNA quality was then
determined by Agilent 2100 bio analyzer (Agilent Technologies)
according to the manufacturer’s recommendations. All samples
used in the study had a RNA integrity number (RIN) number of 7
or above. RNA amplification, hybridization, and detection were
performed at the Genome Technology Access Center, Washington
University in Saint Louis. RNA transcripts were amplified by T7
linear amplification (Message Amp Total Prep amplification kit;
Life Technologies). For reverse transcription, 400 ng of total
cellular RNA sample (11 ml) was mixed with an oligo-dT T7
primer (1 ml), reaction buffer (2 ml, 10x), dNTP mix (4 ml), RNase
Inhibitor (1 ml), and Arrayscript RT enzyme (1 ml) and then
incubated at 42uC for 2 h. After a three minute incubation on ice,
the cDNA underwent second strand synthesis after addition of
water (63 ml), 10x second strand buffer (10 ml), dNTP mix (4 ml),
DNA polymerase (2 ml), and RNase H (1 ml). This cocktail was
incubated at 16uC for two hours. Following a column cleanup
using Zymo DNA Clean and Concentrator 5s (Zymo Research)
according to the manufacturer’s protocol, in vitro-transcription
(IVT) was carried out by adding 10x T7 reaction buffer (2.5 ml),
T7 biotin-NTP mix (2.5 ml), and T7 RNA polymerase enzyme mix
(2.5 ml) and then incubated at 37uC. The IVT reaction was carried
out for 14 hours. Following reaction termination with water
(75 ml), the amplified RNAs (aRNA) were cleaned with RNA
columns provided in the MessageAmp TotalPrep kit. The aRNAs
were then quantitated on a spectrophotometer, and quality
determined by the Agilent 2100 bio analyzer (Agilent Technol-
ogies) according to the manufacturer’s recommendations. 750 mg
of each aRNA in water (5 ml) was suspended in Illumina ‘‘HYB’’
buffer (10 ml), heated to 65uC for five minutes, and allowed to cool
to room temperature. The samples were applied to Illumina
Mouse Ref-8v2 Expression BeadChips and hybridized at 58uC for
16–20 hours at high humidity. Arrays were washed according to
Illumina standard protocol. Immobilized, biotinylated aRNAs
were then detected by staining with cy3 streptavidin (1 mg cy3-SA
per 1 ml of Illumina ‘‘Block E1’’) for 10 minutes at room
temperature. Arrays were washed and dried according to Illumina
standard protocol. Arrays were scanned on an Illumina BeadArray
Reader. Laser power and PMT voltage were kept constant for Cy3
scans. Images were quantitated by Illumina Beadscan, v3.
Statistics and data analysis
Structural parameters from ECHO were normalized to body
weight prior to statistical analysis. Echo and substrate data were
analyzed using a 2-Way ANOVA model (Sex, Genotype,
Sex*Genotype). Microarray data were imported into Illumina
Genome Studio software. On-array spot replicates were averaged
by Genome Studio and individual spot probe was reported. The
bead chip data were normalized using the cubic spline method in
the Illumina Genome Studio software package and exported in
log2 metric. Raw and normalized data sets for all samples involved
have been submitted to the National Center for Biotechnology
Information Gene Expression Omnibus (GEO) repository under
the accession number GSE55936.
A replicated (n= 4) 22 factorial design was used to investigate
the patterns of differentially expressed genes between sexes,
genotypes, and any interactions between these two factors (male
and female mice of wild type and cs-ERa2/2genotypes). The 16
samples were divided between two Illumina Mouse Ref-8v2
Expression Bead Chips in a pattern sufficient to identify and
correct for batch effects, if any, between chips. Probe sets were
filtered from the data set if fewer than 3 replicates in any group
had detection p-values greater than 0.05. The filtered data were
imported into the statistical program Partek Genomics Suite v6.6
for analyses. Initially, a three-way ANOVA model with interaction
(sex, genotype, batch and sex*genotype) was applied to identify
possible batch effects and if necessary to adjust the data
accordingly. The 3-way ANOVA model was reapplied to the
batch adjusted data to determine statistical differences, and this
analysis was followed by contrast comparisons using Fisher Least
Squares difference to determine the statistical significance. Fold
changes between groups were calculated as the antilog of the log
ratio of the two groups of interest (i.e. KO/WT, female/male). It
was expected that the statistical noise (frequency of false positives)
would be greater at low fold changes. Therefore, to confirm the
sensitivity of the analysis with respect to fold change, the analysis
was repeated on 20 different random combinations of the 16 Bead
Chips. The distribution of fold changes for probe sets with a p-
value ,0.05 from the real combinations are plotted in Figure 2A
(between sex) and 2B (between genotype) along with the average
number obtained from the 20 random combinations. This analysis
indicates that, even for fold changes as low as +/21.1; the number
of probe sets identified in the actual combination is higher than
that expected by chance alone. The false discovery rate method of
Benjamin and Hochberg was applied to the p-values from the
ANOVA and contrast analysis. The number of statistically
significant genes as a function of false discovery rate (FDR) level
is shown in Figure 2C for both the genotype and sex differences.
The purpose of this analysis was to determine a FDR level that
would minimize the number of false positives at low fold change
level and still provide a sufficient number of hits for downstream
analysis. As seen in Figure 2C, an FDR of 0.05, the conventionally
accepted level, identifies 208 genes with a genotype difference and
56 genes with sex differences. Although application of an
FDR=0.05 reduces the number of positive hits in the true
comparison, the analysis totally eliminates false positive hits in the
random combinations as depicted in Figure 2A & 2B.
Gene Ontology (GO) and Pathway Analyses
For exploratory analysis, Hierarchical clustering (HCL) of the
significant genes was carried out using Partek genomics suite. HCL
analysis was performed on intensity data derived from the
ANOVA analysis yielding 254 and 74 probe sets that are
differentially expressed between genotype and sex, respectively.
The fold changes were subject to normalization, shifting genes to
mean of zero and standard deviation of one prior to clustering.
Clustering was performed with complete linkage where the
distance between two clusters is equal to the distance between
the two furthest members of those clusters. The results from
clustering analysis are provided in the Figure S1 and S2.
Gene Ontology (GO) Analysis. The significant gene lists,
both for genotype and sex variations, were analyzed using
Metacore. Analysis of the significant probe sets revealed that
there were 208 and 56 identifiable unique genes that were different
Functional, Metabolic, and Network Analysis of cs-ERa2/2 Mice
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between genotype and sex, respectively. The gene set thus
identified at the FDR 0.05 level was used to identify GO pathways
and processes. GO was primarily used to probe the cellular
localization of genes, the processes in which they are involved, the
metabolic networks, and their potential pathways.
Pathway Analysis. To investigate the biological functions of
the differentially expressed genes, pathway analysis was conducted
using MetaCore. Analysis was performed using the 208 genes that
were different between the knockout and wild type mice and for
the 56 genes that were different between sexes. The dataset
containing gene identifiers and corresponding expression values
were uploaded on to the web portal and the identifiers were
mapped to its corresponding object in MetaCore’s knowledgebase.
Networks for the identified and mapped molecules were then
algorithmically generated based on their connectivity. As our
interests were primarily on the modulation of genomic actions by
ERa, we conducted enrichment analysis for pathways and built
network for transcription factors and receptors for the gene list.
The transcription factor network analysis generates a list of
transcription factors that have targets among the uploaded gene
list, and the receptor network generates a list for which ligands are
present in the uploaded data set. It then draws the shortest paths
between these lists. The networks were generated and scored.
FDR threshold has been argued to be too restrictive in
conducting pathway analysis [24]. Therefore, to gain a broader
insight on altered pathways, we have relaxed FDR thresholding.
We used the Compare Experiment Workflow module within
MetaCore to compare variations in gene expression between male
knockout mice to female knockout mice, normalized to their
respective controls. The data identified the intersection network
nodes on Metacore’s various ontologies from the two sexes.
Results and Discussion
In this work, we report on the generation of mice with
cardiomyocyte-specific deletion of ERa (cs-ERa2/2 mice). In
contrast to whole-body ERa knockout mice, which are obese [12]
and exhibit significantly increased serum substrates (e.g., triglyc-
erides, cholesterol, glucose) [13], cs-ERa2/2 mice were viable,
overtly normal, and did not display significant variations in serum
substrate concentrations nor weight (Figure 3). This observation
underscores the significance of using an animal model with cardiac
specific knockout of ERa in place of whole-body ERa knockout to
investigate the role of ERa in the heart since the latter can result in
cardio-metabolic remodeling due to systemic effects of ERa.
To characterize the role of ERa in the heart at baseline, we
assessed differences in cardiac structure and function as well as
performed microarray gene expression profiling on cs-ERa2/2 in
comparison WT mice. Two–way ANOVA of echocardiographic
measurements revealed that with the exception of the peak
velocity of systolic mitral annular motion (S’), there were no
significant genotypic variations in the remaining functional
parameters. However, sex differences were observed in multiple
structural parameters, such as, left ventricle posterior wall
diameter, the left ventricle internal dimension, and the inter-
ventricular septum (Table 1).
Microarray analysis was performed to characterize variations in
gene expression pattern attributed ‘‘genotype’’ and ‘‘sex’’.
ANOVA analysis of the microarray data with a FDR=0.05
identified 208 genotype-specific genes and 56 sex-specific genes
whose expression levels were significantly altered between cs-
ERa2/2and WT mice (Table 1 and 2). With the exception of 8
genes, there was no overlap between the panel of genotypic- and
sex- specific genes. The sensitivity of our analysis was confirmed by
randomization of the dataset as explained in the methods section
and is shown in Figure 2. To characterize these differences, GO
analysis was carried out to identify gene-product differences in
cellular localization, processes, and metabolic networks. The GO
analysis suggested that gene-product differences linked to the
genotype are distinct from those linked to the sex difference
(Figure 4 and 5). In addition, pathway enrichment analysis was
performed to delineate the pathways in which ERa participates,
either directly or indirectly.
Differentially expressed genes attributed to genotype
Fold changes in the expression of 208 genes that were significant
for genotypic variations were imported into MetaCore for GO
enrichment analysis. The top 10 (where applicable) networks and
pathways from this analysis are shown in Figure 4. Figure 4A
shows that the absence of ERa largely affects expression of genes
encoding membrane bound proteins and proteins localized in the
intracellular lumen. The processes in which these gene products
are involved range from regulation of reactive oxygen species
(ROS), stress response, to metabolism of small molecules
(Figure 4B). Our analyses indicated that expression of enzymes
involved in metabolism of carbohydrates and their intermediates
and acyl-L-carnitine pathway were affected by genotype
(Figure 4C). The pathway enrichment analysis indicated that
multiple Notch1-regulated signaling pathways are affected in cs-
ERa2/2mice (Figure 4D). The network of genes included those
Figure 2. Statistical analysis and validation: Histogram for the number of significant genes and their fold changes from the actual
combination of Bead Chips compared to 20 random combinations (p,0.05) are shown for both (A) sex and (B) Genotype. This shows
the number of significantly identified genes in the actual combination is higher than number of false positives expected, even at low fold change.
Number of significant genes as a function of FDR value is shown, at every FDR level genotypic variation is larger than the (C) sex variation. When
corrected for multiple comparison (FDR) no significant fold changes are identified in any of the random combination until FDR= 0.20. Significant
genes were calculated using Partek Genomics Suite, using three way ANOVA model on filtered dataset for signal intensity and batch effect (13, 155
probe sets of 25179) and p value ,0.05, corrected for FDR ,0.05.
doi:10.1371/journal.pone.0101900.g002
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that encode phosphofructokinase, amylase, aldose reductase, and
aldolase (Table 2 and 3).
ERa has been shown to be indispensable for glucose uptake in
mouse heart [11]. Whole body inactivation of ERa results in
obesity, insulin resistance, and glucose intolerance [12,13,25].
Alteration in Glut4 expression due to variations in ERa has been
implicated in insulin resistance and subsequent glucose intolerance
in mice [26]. SP1 and NFkB are key modulators of Glut4, a
prominent glucose transporter [25,27]. In agreement with these
data, the gene network from our results is largely regulated by
three transcription factors; Sp1, Notch 1, and C-Myc (Figure 6A).
Furthermore, we observed that NFkB, along with Sp1, is involved
in regulation of the genes controlling insulin utilization that are
differentially expressed between cs-ERa2/2and WT mice.
Though estrogen activated expression and translocation of
GLUT4 has been shown to be vital for glucose disposal, our
microarray analysis failed to reveal any significant difference in
Glut4 expression between knockout and wild type animals.
However, we observe up regulation of Rab31, a member of the
Ras oncogene family, which is known to modulate glucose
homeostasis by alterations in GLUT4 partitioning between the
cell membrane and intracellular vesicles (Table 2). Similar
observations were made in mouse hearts from whole body ERa
KO where there was no significant changes in mRNA or protein
levels of these transporters, but rather alterations in glucose
transport due to variation in GLUT4 partitioning [28].
In addition to alterations in carbohydrate metabolism, we
observed that the deletion of ERa affects expression of genes
involved in lipid metabolism (Table 2). GO analysis of differen-
tially expressed genes in cs-ERa2/2mice reveals differences in
expression of enzymes involved in acylcarnitine metabolism
(Figure 3C). ERa-mediated regulation of lipogenic genes is well
Figure 3. Weights and Serum substrate levels of wild type and cs-ERa2/2. (A) Weight of mice at the time of study ranging 18–20wks. Serum
substrate concentrations of (B) Glucose, (C) NEFA, (D) Cholesterol and (E) Triglyceride were determined by spectroscopic analysis. Data are
represented as mean 6 SD (N= 4 for each category). *indicates sex difference P,0.05, Two-Way ANOVA.
doi:10.1371/journal.pone.0101900.g003
Table 1. Echocardiographic measurements.
Male WT Female WT Male cs-ERa2/2 Female cs-ERa2/2 Stats
Structural
LVPWId (mm/g) 0.0360.003 0.0460.002 0.0360.006 0.03960.003 a
LVPWIs (mm/g) 0.0560.002 0.0660.003 0.0560.008 0.06160.009 a
LVIDId (mm/g) 0.1260.002 0.1560.011 0.1160.008 0.13260.002 a, b
LVIDIs (mm/g) 0.0660.005 0.0860.010 0.00660.005 0.06760.003 a, b
IVSd 0.87060.06 0.89060.04 0.89060.1401 0.94060.064 a
IVSs 1.42060.15 1.43060.092 1.45060.134 1.51060.256 a
LVM 112.63620.23 107.65617.18 95.74612.60 92.0466.16
LVMI (mg/g) 3.79060.45 4.66060.69 3.25060.45 3.98060.09 a, b
Functional
FS (%) 48.6863.16 47.0163.47 45.8062.91 48.8862.44
E’ (mm/s) 42.4167.77 36.7864.78 33.1665.45 41.0869.90
A’ (mm/s) 33.1666.22 N/A N/A N/A
S’ 34.6361.44 28.1763.10 26.8462.98 28.3264.10 b, c
IVCT (ms) 5.8062.05 6.9662.72 7.7861.43 7.4961.74
ET 38.0563.66 42.1162.26 38.3364.18 41.8663.52
IVRT (ms) 11.5263.65 10.2061.61 12.6762.20 11.5761.78
Tei Index 0.4560.09 0.4160.10 0.5360.04 0.4660.08
All dimensional measurements were indexed to body weight. FS, fractional shortening; E, peak velocity of early diastolic trans-mitral flow; A, peak velocity of late (atria)
diastolic trans-mitral flow; S’, peak velocity of systolic mitral annular motion; E’, peak velocity of early diastolic mitral annular motion; A’, peak velocity of late (atrial)
diastolic mitral annular motion; IVCT, iso-volumic contraction time; ET, LV ejection time; IVRT, iso-volumic relaxation time; Tei Index, LV performance index calculated as
(IVCT+IVRT)/ET. Values given as mean6 SD (N= 4/group). N/A, not available; adenotes sex significance between male and female mice; bdenotes genotypic significance
between wild type and cs-ERa2/2 mice; cInteraction term of ANOVA analysis was significant; P,0.05 was considered significant.
doi:10.1371/journal.pone.0101900.t001
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Table 2. List of significant, differentially expressed genes, attributed to genotype (P,0.05, 2-Way ANOVA) between ER Alpha KO
and Wild type mice.
Gene Name Symbol FC p.value
RNA binding protein, fox-1 homolog A2bp1 21.16 1.87E-04
4-aminobutyrate aminotransferase Abat 1.35 3.27E-04
ATP-binding cassette, sub-family A (ABC1), member 8 Abca8a 1.17 7.17E-04
ATP-binding cassette, sub-family B (MDR/TAP), member 8 Abcb8 21.16 1.82E-04
Acyl-CoA dehydrogenase, C-2 to C-3 short chain Acads 21.16 3.48E-04
Acyl-CoA thioesterase 7 Acot7 21.19 1.07E-05
Acyl-CoA synthetase medium-chain family member 5 Acsm5 21.41 3.29E-04
Aminoacylase 1 Acy1 21.12 9.22E-04
Adenylosuccinate synthase like 1 Adssl1 1.19 4.11E-05
Aldo-keto reductase family 1 member B3 Akr1b3 1.29 6.88E-07
Aldolase B, fructose-bisphosphate Aldob 21.81 2.66E-05
Amylase, alpha 1 Amy1 21.25 8.52E-05
Ankyrin repeat domain 1 (cardiac muscle) Ankrd1 1.67 2.55E-05
Anoctamin 10 Ano10 21.64 1.12E-04
Amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) Apbb1 21.23 1.28E-04
Asialoglycoprotein receptor 2 Asgr2 21.18 1.63E-04
Aspartate beta-hydroxylase Asph 1.34 2.29E-05
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 Atp2a1 2.11 1.20E-04
ATPase, H+ transporting V0 subunit e2 Atp6v0e2 1.43 4.74E-04
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D Atp6v1d 1.14 2.04E-04
Ataxin 1 Atxn1 21.21 4.03E-04
B9 protein domain 2 B9d2 21.17 5.87E-04
Bardet-Biedl syndrome 7 Bbs7 1.16 9.53E-04
Branched chain keto acid dehydrogenase E1, alpha polypeptide Bckdha 21.19 3.92E-05
B-cell CLL/lymphoma 7A Bcl7a 21.18 7.05E-04
Complement component 1, q subcomponent, B chain C1qb 1.30 7.75E-04
Coiled-coil domain containing 80 Ccdc80 1.26 1.68E-05
Chemokine (C-C motif) ligand 27 Ccl27 1.19 2.90E-04
Cyclin G1 Ccng1 1.09 7.59E-04
CD164 molecule, sialomucin Cd164 1.09 9.66E-05
CD84 molecule Cd84 1.24 1.60E-04
CD86 molecule Cd86 1.25 5.93E-04
complement factor properdin Cfp 1.31 6.86E-04
CKLF-like MARVEL transmembrane domain containing 8 Cmtm8 21.17 6.83E-05
Cordon-bleu protein-like 1 Cobll1 21.21 2.13E-04
Coenzyme Q5 homolog, methyltransferase (S. cerevisiae) Coq5 21.10 1.90E-04
COX19 cytochrome c oxidase assembly homolog (S. cerevisiae) Cox19 1.21 3.18E-06
Cysteine-rich protein 2 Crip2 21.05 3.21E-04
Catenin (cadherin-associated protein), alpha 3 Ctnna3 21.44 4.72E-07
CTP synthase 1 Ctps 1.15 5.77E-07
Cathepsin Z Ctsz 1.22 1.67E-04
Dephospho-CoA kinase domain containing Dcakd 21.52 3.97E-08
Dynactin 2 (p50) Dctn2 1.11 1.28E-04
DENN/MADD domain containing 2A Dennd2a 21.64 7.54E-09
DnaJ (Hsp40) homolog, subfamily C, member 30 Dnajc30 21.05 3.37E-04
Destrin (actin depolymerizing factor) Dstn 1.17 4.39E-04
Epoxide hydrolase 1, microsomal (xenobiotic) Ephx1 1.26 4.88E-05
Electron-transfer-flavoprotein, beta polypeptide Etfb 21.10 7.49E-04
Exocyst complex component 2 Exoc2 21.52 5.20E-07
Functional, Metabolic, and Network Analysis of cs-ERa2/2 Mice
PLOS ONE | www.plosone.org 6 July 2014 | Volume 9 | Issue 7 | e101900
Table 2. Cont.
Gene Name Symbol FC p.value
Exocyst complex component 4 Exoc4 1.22 3.29E-05
Coagulation factor XIII, A1 polypeptide F13a1 1.35 7.57E-04
Fatty acid desaturase 1 Fads1 1.22 3.66E-04
Fumarylacetoacetate hydrolase (fumarylacetoacetase) Fah 21.21 7.70E-04
Fumarylacetoacetate hydrolase domain containing 1 Fahd1 1.15 1.05E-04
Family with sequence similarity 122B Fam122b 1.20 8.26E-05
F-box and leucine-rich repeat protein 12 Fbxl12 21.14 8.47E-05
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fcgr3 1.23 3.20E-04
Fer (fms/fps related) protein kinase, testis specific 2 Fert2 21.11 4.35E-04
Flt3-interacting zinc finger protein Fiz1 21.11 5.29E-06
FK506 binding protein 4, 59kDa Fkbp4 21.10 1.47E-04
Fibronectin type III domain containing 5 Fndc5 21.18 7.91E-04
Formyl peptide receptor 2 Fpr2 1.36 6.51E-04
Follistatin-like 4 Fstl4 1.52 7.53E-05
Frataxin Fxn 21.13 7.21E-04
growth arrest-specific 6 Gas6 1.13 4.80E-05
MTOR associated protein, LST8 homolog Gbl 21.15 1.74E-04
Growth differentiation factor 15 Gdf15 1.73 9.05E-05
Glycerophosphodiester phosphodiesterase domain containing 1 Gdpd1 1.16 2.68E-04
Glucose-fructose oxidoreductase domain containing 1 Gfod1 21.16 6.74E-05
Glycolipid transfer protein Gltp 1.18 1.47E-04
Guanine nucleotide binding protein-like 1 Gnal1 21.09 8.67E-04
Golgi SNAP receptor complex member 2 Gosr2 21.14 1.69E-05
G protein-coupled receptor 34 Gpr34 1.32 2.48E-04
Trans-2,3-enoyl-CoA reductase Gpsn2 21.14 8.57E-04
Glyoxylate reductase/hydroxypyruvate reductase Grhpr 1.14 2.72E-05
Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) Grina 1.08 3.02E-04
G protein-coupled receptor kinase 5 Grk5 1.35 7.11E-04
GTF2I repeat domain containing 2 Gtf2ird2 21.13 4.75E-04
Guanylate kinase 1 Guk1 1.14 7.13E-05
High density lipoprotein binding protein Hdlbp 21.17 7.39E-05
HIG1 hypoxia inducible domain family, member 1B Higd1b 21.23 4.71E-04
Histone cluster 1, H2be Hist1h2be 1.19 4.92E-04
Histone cluster 1, H2bk Hist1h2bk 1.13 5.06E-04
Histone cluster 1, H3f Hist1h3f 1.25 3.37E-04
Histone cluster 2, H3b Hist2h3b 1.15 7.65E-04
High mobility group nucleosomal binding domain 2 Hmgn2 21.15 9.83E-06
Hematological and neurological expressed 1 Hn1 1.44 1.93E-06
Heat shock 27kDa protein 1 Hspb1 1.09 8.78E-04
Islet cell autoantigen 1, 69kDa Ica1 21.10 7.54E-04
Interferon-induced protein with tetratricopeptide repeats 2 Ifit2 1.23 1.37E-04
Interleukin 13 receptor, alpha 1 Il13ra1 1.12 2.90E-04
Interleukin 15 Il15 21.24 2.63E-04
Interleukin 28 receptor, alpha (interferon, lambda receptor) Il28ra 1.18 4.94E-04
IMP2 inner mitochondrial membrane peptidase-like Immp2l 21.63 1.97E-10
Insulin-like 6 Insl6 1.27 2.35E-04
Importin 13 Ipo13 21.23 6.57E-04
IQ motif containing GTPase activating protein 2 Iqgap2 1.23 2.53E-04
Potassium voltage-gated channel, Isk-related family, member 1 Kcne1 21.25 7.06E-05
Potassium channel, subfamily V, member 2 Kcnv2 21.47 2.12E-05
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Gene Name Symbol FC p.value
Lysosomal protein transmembrane 5 Laptm5 1.26 1.82E-04
Lipocalin 2 Lcn2 1.75 8.75E-05
Lectin, galactoside-binding, soluble, 3 Lgals3 2.08 2.05E-07
Lysozyme Lyz 1.38 9.78E-05
Lysozyme 2 Lyz2 1.59 2.60E-06
Membrane associated guanylate kinase, WW and PDZ domain containing 3 Magi3 1.29 7.62E-04
MAGI family member, X-linked Magix 21.19 4.79E-04
Mitogen-activated protein kinase kinase kinase 3 Map3k3 21.08 4.28E-04
Mitogen-activated protein kinase 11 Mapk11 21.15 5.09E-04
Methyltransferase like 17 Mett11d1 21.18 5.63E-04
Monoglyceride lipase Mgll 21.12 6.07E-04
Matrix metallopeptidase 23B Mmp23 1.21 6.32E-04
Mannose receptor, C type 1 Mrc1 1.32 7.27E-06
Mitochondrial ribosomal protein S9 Mrps9 21.15 1.10E-04
Myosin binding protein C, fast type Mybpc2 1.72 4.45E-07
NCK-associated protein 1-like Nckap1l 1.29 6.74E-05
Niemann-Pick disease, type C2 Npc2 1.15 6.35E-04
Natriuretic peptide A Nppa 2.10 1.37E-05
Nuclear receptor binding protein 2 Nrbp2 1.28 1.06E-04
Nucleotide binding protein 1 Nubp1 1.26 2.33E-05
Nudix (nucleoside diphosphate linked moiety X)-type motif 5 Nudt5 1.19 8.72E-05
Oxysterol binding protein-like 3 Osbpl3 1.27 1.15E-04
Organic solute transporter alpha Osta 1.47 1.98E-07
Prolyl 4-hydroxylase, beta polypeptide P4hb 1.21 2.27E-04
Pantothenate kinase 3 Pank3 21.20 3.59E-04
Polyamine oxidase (exo-N4-amino) Paox 1.19 8.89E-04
Poly (ADP-ribose) polymerase family, member 12 Parp12 21.45 2.67E-06
Polycomb group ring finger 6 Pcgf6 1.12 6.88E-04
Pyruvate dehydrogenase kinase, isozyme 1 Pdk1 21.19 7.92E-05
Pyruvate dehydrogenase kinase, isozyme 2 Pdk2 21.16 1.15E-04
Phosphofructokinase, platelet Pfkp 1.34 4.65E-07
Pleckstrin homology-like domain, family A, member 3 Phlda3 1.60 7.20E-08
Paired-Ig-like receptor A4 Pira4 1.28 4.21E-05
Protein kinase (cAMP-dependent, catalytic) inhibitor alpha Pkia 21.10 9.53E-04
Plakophilin 2 Pkp2 1.16 5.05E-04
Phospholipase C, gamma 2 (phosphatidylinositol-specific) Plcg2 1.27 5.66E-04
Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8 Plekha8 1.18 7.06E-04
Protein kinase C, delta Prkcd 1.24 5.12E-07
Prolactin receptor Prlr 21.35 3.99E-06
Protein arginine methyltransferase 2 Prmt2 1.19 2.88E-04
Prion protein-interacting protein1 Prnpip1 21.17 9.65E-04
Phosphoserine aminotransferase 1 Psat1 1.25 5.77E-04
Prostaglandin D2 synthase 21kDa (brain) Ptgds 1.48 2.15E-04
Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A Ptpla 21.14 5.96E-04
Protein tyrosine phosphatase, receptor type, O Ptpro 1.33 5.63E-04
Polymerase I and transcript release factor Ptrf 21.21 8.29E-04
RAB31, member RAS oncogene family Rab31 1.27 3.87E-05
RAB3D, member RAS oncogene family Rab3d 1.17 6.39E-04
RAB, member of RAS oncogene family-like 3 Rabl3 21.11 3.71E-04
RAP2B, member of RAS oncogene family Rap2b 1.16 5.28E-04
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Gene Name Symbol FC p.value
RNA binding motif protein 38 Rbm38 21.13 6.17E-04
RNA binding motif protein 47 Rbm47 1.20 8.04E-04
Rhomboid, veinlet-like 3 (Drosophila) Rhbdl3 21.19 1.07E-04
Ring finger protein 135 Rnf135 21.15 3.49E-04
Ring finger protein 208 Rnf208 1.36 5.56E-04
Retinal outer segment membrane protein 1 Rom1 1.26 2.63E-05
Ribonuclease P/MRP 25kDa subunit Rpp25 1.46 2.87E-07
S100 calcium binding protein A13 S100a13 1.25 5.25E-04
SH3-binding domain kinase 1 Sbk 21.19 3.42E-04
Secretory carrier membrane protein 5 Scamp5 1.26 9.10E-04
SH3-domain binding protein 2 Sh3bp2 1.18 2.58E-04
SH3-binding domain protein 5-like Sh3bp5l 1.11 1.71E-04
Src homology 2 domain containing transforming protein D Shd 1.43 3.42E-06
Serine hydroxymethyltransferase 2 (mitochondrial) Shmt2 21.16 1.89E-05
Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 Slc17a7 1.57 3.16E-05
Solute carrier family 19 (thiamine transporter), member 2 Slc19a2 1.29 1.58E-05
Solute carrier family 25, member 34 Slc25a34 21.20 7.43E-04
Solute carrier family 35, member B4 Slc35b4 1.17 9.44E-05
Solute carrier family 39 (zinc transporter), member 13 Slc39a13 1.13 7.25E-04
Solute carrier family 45, member 2 Slc45a2 21.13 5.25E-04
Solute carrier family 7 (orphan transporter), member 4 Slc7a4 1.17 4.59E-04
Single-strand-selective monofunctional uracil-DNA glycosylase 1 Smug1 21.28 1.92E-04
Small nuclear RNA activating complex, polypeptide 4, 190kDa Snapc4 1.13 9.39E-04
Single-stranded DNA binding protein 2 Ssbp2 21.40 3.07E-04
Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 Svep1 1.26 2.82E-04
Tachykinin, precursor 1 Tac1 21.37 7.12E-04
TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa Taf15 21.43 3.55E-04
Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) Tceb1 1.12 3.18E-04
Tescalcin Tesc 21.29 1.69E-04
Translocase of inner mitochondrial membrane 10 homolog (yeast) Timm10 1.15 2.20E-06
TIMP metallopeptidase inhibitor 1 Timp1 2.81 7.81E-06
Toll-like receptor 2 Tlr2 1.25 3.46E-04
Transmembrane channel-like 7 Tmc7 1.14 6.57E-04
Transmembrane protein 141 Tmem141 1.11 3.90E-05
Transmembrane protein 164 Tmem164 21.32 7.42E-05
Transmembrane protein 167A Tmem167 1.19 9.09E-05
Transmembrane protein 176B Tmem176b 1.33 1.36E-05
Transmembrane protein 38A Tmem38a 21.11 4.82E-04
Transmembrane protein 43 Tmem43 1.11 9.58E-04
Transmembrane protein 62 Tmem62 1.17 4.07E-04
Tumor protein D52 Tpd52 1.19 4.55E-05
Thiamin pyrophosphokinase 1 Tpk1 1.24 4.81E-04
Trafficking protein particle complex 2-like Trappc2l 21.11 1.74E-04
Tripartite motif containing 21 Trim21 21.18 9.21E-04
TROVE domain family, member 2 Trove2 1.23 5.84E-04
Tetraspanin 12 Tspan12 1.25 4.27E-05
Tetraspanin 17 Tspan17 1.26 6.30E-05
Translocator protein (18kDa) Tspo 1.17 4.39E-05
Tubulin tyrosine ligase-like family, member 1 Ttll1 21.32 1.03E-06
Uracil-DNA glycosylase Ung 21.36 4.05E-04
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documented [29,30]. For example, observed variations in
desaturase enzyme mRNA expression (Table 2) and activity have
been implicated in altering insulin sensitivity in whole body ERa
knockout [31,32].
Core regulators of genes that vary by genotype
Because ERa is known to have significant regulatory roles in
transcriptional modulation and receptor mediated signaling,
network analysis was performed to identify differentially expressed
networks between cs-ERa2/2and WT mice. Our analysis suggests
that the transcription factors Stimulating protein 1 (SP1), Estrogen
Receptor Alpha (ERa), and C-Myc are at the hub of transcrip-
tional modulation connecting most of the significant differentially
expressed genes (Figure 6A). More than seventy-five genes were
differentially expressed among these three networks, with nearly
one-third being down-regulated and two-thirds being up-regulated
in cs-ERa2/2 mice. In addition, thirteen genes coding for
receptors and five genes coding for receptor ligands were
differentially expressed in the cs-ERa2/2 mice (Figure 6B). All
of the genes coding for receptors were up-regulated in cs-ERa2/2
Table 2. Cont.
Gene Name Symbol FC p.value
Uridine phosphorylase 1 Upp1 1.27 1.27E-04
Uridine phosphorylase 2 Upp2 21.13 6.90E-04
Ubiquinol-cytochrome c reductase core protein I Uqcrc1 21.08 9.37E-04
Ubiquitin specific peptidase 16 Usp16 1.21 6.76E-04
Vacuolar protein sorting 29 homolog Vps29 1.13 6.37E-05
WNT1 inducible signaling pathway protein 2 Wisp2 1.38 4.74E-04
Yes-associated protein 1 Yap1 21.14 5.88E-04
Zinc finger, DHHC-type containing 12 Zdhhc12 1.21 5.14E-04
Zinc finger protein 398 Zfp398 21.22 4.71E-04
doi:10.1371/journal.pone.0101900.t002
Figure 4. GO Enrichment Analysis for top hits of genotype significant Genes: GO Term analysis were performed using GeneGo on
the list of significant genes varying by genotype, FDR ,0.05. Top 10 hits (where applicable) is presented for (A) Localization, (B) Cellular
Processes, (C) Metabolic Networks, and (D) Pathway Enrichment. P values for GO analysis are calculated based on hypergeometric distribution. The P-
values on the graph indicate the probability of mapping of an experiment to a process to arise by chance.
doi:10.1371/journal.pone.0101900.g004
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mice, with the exception of the genes coding for prolactin receptor
and C-type lectin receptor Clec10a. The up-regulated genes
include a G protein-coupled receptor (GPCR) type receptor;
interleukin 13 receptor alpha 1 (Il13ra1); Notch 1 precursor; toll-
like receptor 2 (Tlr2); and interleukin 28 receptor alpha (Il28ra),
several of which have known roles in cardiac metabolism.
Differentially expressed genes attributed to sex
The GO analysis based on sex is distinct from that of genotype.
The primary sites of localization for sex significant gene-products
are in the extracellular space and matrix (Figure 5A). The list of
processes shown in Figure 5B suggests that, NOS signaling and
processes involved in smooth muscle relaxation are affected the
most, primarily due to variations in expression levels of the genes
Gucy1a3, Emilin2, and Lum (Table 3). The metabolic network
analysis indicates that the genes that are differentially expressed
between male and female have roles in amino acid and steroid
metabolism (Figure 5C). The genes that are significantly different
include Bcat1, Eif2s3y, Fah, Inmt, and Haghl, which are all down
regulated and Diras2, Lum, and Ovgp1, which are up-regulated
(Table 3). Finally, GO pathway enrichment analysis indicates that
signaling pathways with a primary role in immune response, such
as the JAK-STAT pathway, TICAM signaling, TLR signaling,
Oncostatin signaling (Figure 5D), are primarily affected.
Core regulators of genes that vary by sex
Network analysis based on sex difference presents a smaller
network of receptor genes compared to genotypic differences.
Only one receptor coding gene, Ly96 (MD-2), is down-regulated
in females. However, there are 4 receptor ligand encoding genes
that are differentially expressed between female and male mice. In
females, Pf4 (Cxcl4) and Ccl11 (Eotaxin) are down-regulated
whereas Mdk (Midkine) and Ptn (Pleiotrophin) are up-regulated
(Figure 7A). As observed in our analysis between genotypes
(previous section), we find that Stat3, Stat5, Znf, Sp1 and Esr1
(ERa are at the core connecting a larger proportion of these
differentially expressed genes (Figure 7B).
Novel candidates for ERa mediated regulation of cardiac
function
Table 4 lists novel significant (FDR ,0.05) genes that are
directly regulated by ERa. While additional studies are needed to
characterize their role in regulating cardiac function and biology,
in-depth analysis of the genes and their networks may provide
understanding of the role of ERa in the heart. For example, we
observe that WNT1 inducible signaling pathway protein 2 (Wisp2)
is differentially expressed and is directly under regulation of ERa.
While Wnt/b-catenin signaling, both canonical and non-canon-
ical, has been implicated in cardiac function [33–35], there has
been no direct evidence for the cross talk between these two key
pathways (ERa and Wnt/b-catenin). As mentioned earlier in
methods section, to understand how Wnt Signaling may be
affected by the absence of ERa, we relaxed the FDR thresholding
and subjected the data to Compare Experiment Workflow in
MetaCore. Our analysis suggests that there are sex differences in
the Wnt/b-catenin signaling pathway. We observe that several key
effectors of the WNT canonical signaling pathway such as frizzled
receptor (Fzd), b-catenin, GSK- 3b, Tcf, and Sfrp1 are
differentially affected in male and female ERa2/2 mice (i.e. both
sex and genotype differences are observed) (Figure 8 A, B). Similar
effects of ERa regulation of Wnt, b-catenin signaling pathways
have been reported in. the uterus by Hewitt et al [36]. Taken
together, additional studies are needed to fully characterize the
interplay and impact of ERa with Wnt/b-catenin signaling
pathway, among others, in cardiac function.
Figure 5. GO Enrichment Analysis for top hits of sex significant Genes: GO Term analysis were performed using MetaCore from
GeneGo on the list of significant genes varying by sex, FDR ,0.05. Top 10 hits (where applicable) are presented for (A) Localization, (B)
Cellular Processes, (C) Metabolic Networks, and (D) Pathway Enrichment. P values are calculated based on hypergeometric distribution. The P-values
on the graph indicate the probability of mapping of an experiment to a process to arise by chance.
doi:10.1371/journal.pone.0101900.g005
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Table 3. List of significant, differentially expressed genes, attributed to sex (P,0.05, 2-Way ANOVA) between cs-ERa2/2 and Wild
type mice.
Gene Name Symbol FC p.value
Branched chain amino-acid transaminase 1, cytosolic Bcat1 21.20 3.09E-05
Fumarylacetoacetate hydrolase (fumarylacetoacetase) Fah 21.26 1.77E-04
Glycosyltransferase 8 domain containing Glt8d1 1.14 1.34E-04
Immunoglobulin superfamily, member 1 Igsf1 21.32 1.08E-04
Cytochrome P450, family 27, subfamily A, polypeptide Cyp27a1 21.20 1.60E-04
Guanylate cyclase 1, soluble, alpha 3 Gucy1a3 1.37 1.57E-04
Hydroxyacylglutathione hydrolase-like Haghl 21.21 1.94E-04
Coenzyme Q5 homolog, methyltransferase Coq5 21.11 9.35E-05
Eotaxin Ccl11 21.75 1.02E-05
Bone morphogenetic protein-binding endothelial cell precursor-derived regulator Bmper 21.38 1.68E-04
Hydroxysteroid (11-beta) dehydrogenase 1 Hsd11b1 -2.40 1.50E-08
Collagen, type XIV, alpha Col14a1 1.31 6.32E-05
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked Ddx3y 216.45 7.96E-16
DIRAS family, GTP-binding RAS-like Diras2 1.20 1.91E-04
Chemokine (C-X-C motif) ligand Cxcl14 21.68 1.42E-06
DnaJ (Hsp40) homolog, subfamily C, member 30 Dnajc30 21.07 1.13E-05
Eukaryotic translation elongation factor 1 delta Eef1d 1.10 1.46E-04
Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa pseudogene Eif2s3x 1.59 3.08E-07
Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa pseudogene Eif2s3y -9.75 9.63E-14
Eukaryotic translation initiation factor 4E family member 3 Eif4e3 21.14 1.13E-04
Elastin microfibril interfacer 2 Emilin2 1.20 2.43E-04
Guanine nucleotide binding protein (G protein), gamma 8 Gng8 1.33 2.33E-04
Golgi SNAP receptor complex member 2 Gosr2 21.12 8.56E-05
G protein-coupled receptor associated sorting protein 1 Gprasp1 1.22 1.50E-04
Indolethylamine N-methyltransferase Inmt -2.23 8.35E-05
Potassium voltage-gated channel, Isk-related family, member 1 Kcne1 2.32 1.04E-04
Kinesin family member 3C Kif3c 1.14 1.18E-04
Kallikrein 1-related petidase b26 Klk1b26 21.34 1.46E-04
Lysyl oxidase Lox 21.40 2.20E-04
Keratan sulfate proteoglycan lumican Lum 1.48 1.94E-04
Myeloid differentiation protein-2 Ly96 21.06 9.58E-05
Microspherule protein 1 Mcrs1 1.12 2.60E-04
Midkine (neurite growth-promoting factor 2) Mdk 1.52 2.64E-06
Nidogen 1 Nid1 21.20 1.17E-04
Organic solute transporter alpha Osta 1.27 2.45E-05
Oviductal glycoprotein 1, 120kDa Ovgp1 1.22 2.55E-05
Pleiotrophin Ptn 1.78 3.82E-08
RAS-like, family 10, member B Rasl10b 21.27 5.37E-05
Ring finger protein 219 Rnf219 1.19 2.55E-05
Serpin peptidase inhibitor, clade A Serpina3n -2.57 1.60E-04
Solute carrier family 1 (glial high affinity glutamate transporter), member 3 Slc1a3 1.26 2.54E-04
Slowmo homolog 2 (Drosophila) Slmo2 21.10 1.38E-04
Sortilin 1 Sort1 1.22 6.28E-05
Vesicle-associated membrane protein 7 Sybl1 1.43 1.82E-06
Epicardin Tcf21 1.27 2.55E-04
Tudor domain-containing protein 2 Tdrkh 1.21 2.57E-04
Transmembrane protein 141 Tmem141 21.10 1.07E-04
Transmembrane protein 201 Tmem201 1.17 2.41E-05
Transmembrane protein 38A Tmem38a 21.14 9.36E-05
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Conclusion
In conclusion, cs-ERa2/2 mice raised under normal diet in
absence of external stress were viable and overtly normal. Our
data suggests that ERa modulates numerous genes in the heart
that are involved in transcriptional regulation, metabolic control,
and oxidative stress in a sex-specific manner. This study has
identified potential networks through which ERa may affect
Table 3. Cont.
Gene Name Symbol FC p.value
Transmembrane protein 82 Tmem82 1.35 5.97E-05
TruB pseudouridine (psi) synthase homolog 2 Trub2 21.16 1.42E-04
Ubiquitin specific peptidase 18 Usp18 1.26 7.17E-05
Histone demethylase UTX Utx 1.82 5.11E-07
Vesicle-associated membrane protein 4 Vamp4 1.14 1.37E-04
WNT1 inducible signaling pathway protein 2 Wisp2 -2.03 3.17E-07
X (inactive)-specific transcript (non-protein coding) Xist 2.23 2.35E-08
doi:10.1371/journal.pone.0101900.t003
Figure 6. Network analysis of genes significant for genotype: List of significant genes (root list) varying by genotype was uploaded
on to GeneGo portal and network built. Transcription factor network (A) was drawn using analyze network function for transcription factors. In
this analysis for every transcription factor with direct ligand (s) in the root list, the algorithm generates a sub-network consisting of all shortest paths
from that transcription factor to the closest receptor with direct target (s) in the root list. Receptor networks (B) was drawn using build network for
your data option. Except receptors and receptor ligands, others were hidden from this network in order to visualize the alteration in receptor
networks. The figure shows the differentially expressed genes in the network (Blue for down-regulated and Red for up-regulated).
doi:10.1371/journal.pone.0101900.g006
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cardiac biology. Our study also identified novel genes that are
potentially under direct regulation by ERa and whose role in the
heart is yet unclear, and we have shown how their biological
relevance can be identified through Wnt signaling. It is likely that
alterations in the dietary pattern, aging, or induction of metabolic
stress could reveal additional phenotypic and metabolic differences
for which further studies could lead to a better understanding of
cardiac biology and potentially, improved treatment in a sex-
dependent manner.
Figure 7. Network analysis of genes significant for sex: List of significant genes (root list) varying by sex was uploaded on to
GeneGo tool and network was built. Receptor networks (A) was drawn using build network for your data option. Except receptors and receptor
ligands, others were hidden from this network in order to visualize the alteration in receptor networks.. Transcription factor network (B) was drawn
using analyze network function for transcription factors. In this analysis for every transcription factor with direct ligand (s) in the root list, the
algorithm generates a sub-network consisting of all shortest paths from that transcription factor to the closest receptor with direct target (s) in the
root list. The figure shows the differentially expressed genes in the network (Blue for down-regulated and Red for up-regulated).
doi:10.1371/journal.pone.0101900.g007
Table 4. List of significantly different genes (P,0.05, 2-Way ANOVA) between cs-ERa2/2 and Wild type mice and networked
directly to ERa.
Gene Name Symbol FC p.value
ATP-binding cassette, sub-family A (ABC1), member 8 Abca8a 1.17 7.17E-04
Aldo-keto reductase family 1 member B3 Akr1b3 1.29 6.88E-07
Ankyrin repeat domain 1 (cardiac muscle) Ankrd1 1.67 2.55E-05
Electron-transfer-flavoprotein, beta polypeptide Etfb 21.10 7.49E-04
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fcgr3 1.23 3.20E-04
Fumarylacetoacetate hydrolase domain containing 1 Fahd1 1.15 1.05E-04
Flt3-interacting zinc finger protein Fiz1 21.11 5.29E-06
growth arrest-specific 6 Gas6 1.13 4.80E-05
Growth differentiation factor 15 Gdf15 1.73 9.05E-05
Heat shock 27kDa protein 1 Hspb1 1.09 8.78E-04
Lipocalin 2 Lcn2 1.75 8.75E-05
Natriuretic peptide A Nppa 2.10 1.37E-05
Protein kinase (cAMP-dependent, catalytic) inhibitor alpha Pkia 21.10 9.53E-04
Protein kinase C, delta Prkcd 1.24 5.12E-07
Prolactin receptor Prlr 21.35 3.99E-06
Prostaglandin D2 synthase 21kDa (brain) Ptgds 1.48 2.15E-04
RAB31, member RAS oncogene family Rab31 1.27 3.87E-05
Retinal outer segment membrane protein 1 Rom1 1.26 2.63E-05
Solute carrier family 19 (thiamine transporter), member 2 Slc19a2 1.29 1.58E-05
Solute carrier family 7 (orphan transporter), member 4 Slc7a4 1.17 4.59E-04
Single-stranded DNA binding protein 2 Ssbp2 21.40 3.07E-04
Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 Svep1 1.26 2.82E-04
Tetraspanin 17 Tspan17 1.26 6.30E-05
WNT1 inducible signaling pathway protein 2 Wisp2 1.38 4.74E-04
doi:10.1371/journal.pone.0101900.t004
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Supporting Information
Figure S1 Hierarchical Cluster analysis of genotype
significant genes from cardiac mRNA microarray re-
sults. mRNA expression patterns were established for cardiac
tissue from both male and female, ERa 2/2 and wild type mice.
HCL analysis was performed on intensity data using partek
genomic suites for the significant gene list. FDR (0.05) corrected
genes with a p value of 0.05 or less were considered significant.
(DOCX)
Figure S2 Hierarchical Cluster analysis of sex signifi-
cant genes from cardiac mRNA microarray results.
mRNA expression patterns were established for cardiac tissue
from both male and female, ERa 2/2 and wild type mice. HCL
analysis was performed on intensity data using partek genomics
suite for the significant gene list. FDR (0.05) corrected genes with a
p value of 0.05 or less were considered significant.
(DOCX)
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